Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EPX | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | SLFN12L | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | MAP3K15 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | GYPA | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | GOLGA8R | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | NKD2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | ZNF648 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | MTHFD1L | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | SYVN1 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
mRNA | FOXB1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |